Bio-Techne (TECH) Free Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -1.95% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -20.15% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 21.16% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 45.09% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 80.69% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -4.45% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 8.92% |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 6.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.21% |
| Mar 31, 2026 | 25.99% |
| Dec 31, 2025 | 9.49% |
| Sep 30, 2025 | -21.83% |
| Jun 30, 2025 | 1.53% |
| Mar 31, 2025 | -18.86% |
| Dec 31, 2024 | -5.14% |
| Sep 30, 2024 | 8.90% |
| Jun 30, 2024 | -19.61% |
| Mar 31, 2024 | 0.15% |
| Dec 31, 2023 | -4.28% |
| Sep 30, 2023 | -5.97% |
| Jun 30, 2023 | 38.32% |
| Mar 31, 2023 | -1.17% |
| Dec 31, 2022 | 1.42% |
| Sep 30, 2022 | 15.73% |
| Jun 30, 2022 | 26.29% |
| Mar 31, 2022 | 18.65% |
| Dec 31, 2021 | 29.36% |
| Sep 30, 2021 | 6.31% |